| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), CALC's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.53M | - | - | |
| 10% | 1.06M | $854.1K | - | |
| CEO | 360.0K | - | - | |
| CFO | 190.0K | - | - | |
| Other | 186.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2023 | Bjerkholt Eric71 | Director | Buy | 200 | $2.65 | $530.00 | +7.3% | - | - | |
| May 18, 2023 | Bjerkholt Eric71 | Director | Buy | 1,300 | $2.70 | $3,504.00 | +91.0% | - | - | |
| May 17, 2023 | Roberts Eric W58 | Chief Business Officer | Buy | 8,300 | $2.70 | $22,421.00 | -127.7% | - | - | |
| May 16, 2023 | Hebbar Sudarshan71 | Chief Medical Officer | Buy | 10,000 | $2.70 | $26,999.00 | New | - | - | |
| May 16, 2023 | Leheny A. Rachel47 | Chief Executive Officer | Buy | 1,000 | $2.69 | $2,690.00 | New | - | - | |
| Mar 31, 2022 | Breuil Robert S | Chief Financial Officer | Sale+OE | 2,188 | $1.25 | $2,735.00 | -9.6% | -10.6% | - | |
| Sep 22, 2021 | Breuil Robert S | Chief Financial Officer | Sale+OE | 7,283 | $3.55 | $25,853.92 | -36.4% | -43.0% | -72.8% | |
| Sep 29, 2020 | Shaffer Christy L | Director | Buy | 18,750 | $16.00 | $300,000.00 | +1.2% | - | - | |
| Sep 29, 2020 | Flynn James E | 10% Owner, *possible Member Of 10% Group | Buy | 1,562,500 | $16.00 | $25,000,000.00 | +536.1% | - | - | |
| Sep 25, 2020 | Orbimed Advisors LLC66 | 10% Owner | Buy | 562,500 | $16.00 | $9,000,000.00 | New | - | - |